Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
multiple sclerosis/albumin
Länken sparas på Urklipp
Sida 1 från 16 resultat
Transcranial Magnetic Stimulation (TMS) in Multiple Sclerosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
It is based on the hypothesis that the application of transcranial magnetic stimulation (TMS) at 1 Hertz or 5 Hertz in patients with relapsing-remitting multiple sclerosis (RRMS) implies a neuroprotective effect against the progression of the disease, resulting in a clinical improvement (attenuation
Open Trail of γIFN for Friedreich Ataxia
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Friedreich ataxia (FRDA) is a devastating neurodegenerative disease that affects children and young adults. Patients become progressively unable to coordinate movements and walking until severe disability ensues. Most patients develop dilated cardiomyopathy and congestive heart failure. The disease
Incomes of Nutritional Support Modalities in Hemodialysis Patients With Severe Malnutrition
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Our current standard nutrition care is based upon existing recommendations and involves nutrition counselling for optimal dietary intake from food and beverages, food fortification, administration of oral nutrition supplementation (ONS) and/or IDPN in malnourished MHD patients.
Among 712 MHD
Central and Peripheral Nervous System Changes as Markers of Disease Progression in Multiple Sclerosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND Multiple Sclerosis (MS) is an autoimmune, inflammatory demyelinating disease targeting myelinated axons in the Central Nervous System (CNS). It is the most common nontraumatic cause of disability in young people. Most MS patients are diagnosed between the ages of 20 and 40 years. Denmark
Vitamin D Supplementation and Sunlight Exposure in Brazilian Women Living in Opposite Latitudes (The D-SOL Study)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
During this study the subjects were asked to visit the Clinical Investigation Unit, FHMS, University of Surrey in the UK or the Research Clinic, Faculty of Nutrition, Federal University of Goiás in Brazil, on two occasions, at the beginning of the study for baseline measurements and at the
Non-interventional Study to Assess Adherence to Treatment for Patients With Relapsing Multiple Sclerosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
3 Background The use of cardiopulmonary bypass (CPB) during cardiac surgery elicits generalized non-specific systemic inflammatory response syndrome (SIRS) and subsequent activation of the cytokine, complement, and coagulation-fibrinolytic cascades (1). In approximately 11% of the patients SIRS may
Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Primary biliary cirrhosis (PBC) is a slowly progressive cholestatic disease associated with the development of cirrhosis and liver failure that may justify liver transplantation. Ursodeoxycholic acid (UDCA) is currently the only drug approved specifically for the treatment of PBC. However, one out
The Effects of Interferon Beta Combined With Vitamin D on Relapsing Remitting Multiple Sclerosis Patients
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Detailed Description of Study Evaluations
Adherence to treatment evaluation:
Patients will be asked to bring the empty packages of the IFN beta and Vitamin D that were used during the study.
Flu like symptoms and Injection site reactions evaluation:
Data regarding FLS and ISRs will be collected by
Functional and Physiological Responses to Lokomat Therapy (Pilot Study)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Description of the Clinical Lokomat Therapy program:
This is a 12-week program with 3 to 5 sessions per week. Each session includes: 15-20 minutes of patient set-up (set-up time becomes about 5 to 10 minutes after a few sessions), 5-10 minutes of warm-up, 20-40 minutes of Lokomat therapy, 5-10
Long-term Follow-Up of Patients Who Participated in Study 27025 (REFLEX)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
The objective of the study is to investigate whether RNF treatment initiated after the first clinical event versus delayed treatment results in the prolongation of time to Clinically Definite Multiple Sclerosis (CDMS) conversion up to Month 36 and up to Month 60 since randomization in Study 27025
Botox-A Injection to Improve Bladder Function in Early Spinal Cord Injury (#H-20344)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Approximately 10,000 spinal cord injuries (SCI) occur each year, most of which occur in males (80%). Many of these patients develop neurogenic bladder dysfunction (NGB) characterized by overactivity of the detrusor muscle, termed detrusor overactivity (DO) or detrusor hyperreflexia (DH). They can
REbif FLEXible Dosing in Early Multiple Sclerosis (MS)
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
Immune Globulin Intravenous (IGIV) To Treat Relapsing, Remitting Multiple Sclerosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This trial is designed as a multi-national, randomized, double-blind, placebo-controlled prospective trial with three parallel groups.
One hundred twenty (120) patients, 40 per treatment arm, with relapsing-remitting (RR) multiple sclerosis will be enrolled in this trial. Eligible patients must have
Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
As has been seen with other recombinant protein molecules, the use of injectable recombinant proteins may result in the development of neutralising antibodies (NAbs). Antibodies are considered neutralising by their ability to inhibit the biological effect of interferon in a bioassay system. EMD
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
